Artesunate AMIVAS, approved by EU Commission and U.K.’s Medicine and Healthcare Product Regulatory Agency to treat severe malaria both in children and adults in Europe, is the only fully ...
Researchers have identified a rise in airport and luggage malaria cases in Europe between 2018 and 2022, with numbers significantly increasing since 2000. Health experts suggest climate change and ...
AMIVAS Ireland Ltd (AMIVAS), a biopharmaceutical company focused on developing, commercialising, manufacturing and distributing artesunate for the treatment of severe malaria, today announced the ...